Ramm Robert, Goecke Tobias, Köhler Peter, Tudorache Igor, Cebotari Serghei, Ciubotaru Anatol, Sarikouch Samir, Höffler Klaus, Bothe Friederike, Petersen Björn, Haverich Axel, Niemann Heiner, Hilfiker Andres
Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Hannover Medical School, Carl-Neuberg Str. 1, Hannover 30625, Germany.
Department of Cardiac-, Thoracic-, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg Str. 1, Hannover 30625, Germany.
Regen Biomater. 2021 Aug 3;8(5):rbab036. doi: 10.1093/rb/rbab036. eCollection 2021 Oct.
Decellularization of xenogeneic heart valves might lead to excellent regenerative implants, from which many patients could benefit. However, this material carries various xenogeneic epitopes and thus bears a considerable inherent immunological risk. Here, we investigated the regenerative and immunogenic potential of xenogeneic decellularized heart valve implants using pigs deficient for the galactosyltransferase gene (GGTA1-KO) as novel large animal model. Decellularized aortic and pulmonary heart valves obtained from sheep, wild-type pigs or GGTA1-KO pigs were implanted into GGTA1-KO pigs for 3, or 6 months, respectively. Explants were analyzed histologically, immunhistologically (CD3, CD21 and CD172a) and anti-αGal antibody serum titers were determined by ELISA. Xenogeneic sheep derived implants exhibited a strong immune reaction upon implantation into GGTA1-KO pigs, characterized by massive inflammatory cells infiltrates, presence of foreign body giant cells, a dramatic increase of anti-αGal antibody titers and ultimately destruction of the graft, whereas wild-type porcine grafts induced only a mild reaction in GGTA1-KO pigs. Allogeneic implants, wild-type/wild-type and GGTA1-KO/GGTA1-KO valves did not induce a measurable immune reaction. Thus, GGTA1-KO pigs developed a 'human-like' immune response toward decellularized xenogeneic implants showing that immunogenicity of xenogeneic implants is not sufficiently reduced by decellularization, which detracts from their regenerative potential.
异种心脏瓣膜的去细胞化可能会产生出色的再生植入物,许多患者可能从中受益。然而,这种材料带有各种异种抗原表位,因此存在相当大的固有免疫风险。在此,我们使用缺乏半乳糖基转移酶基因(GGTA1-KO)的猪作为新型大型动物模型,研究了异种去细胞化心脏瓣膜植入物的再生和免疫原性潜力。分别从绵羊、野生型猪或GGTA1-KO猪获得的去细胞化主动脉和肺动脉心脏瓣膜被植入GGTA1-KO猪体内3个月或6个月。对植入物进行组织学、免疫组织学分析(CD3、CD21和CD172a),并通过ELISA测定抗αGal抗体血清滴度。异种绵羊来源的植入物在植入GGTA1-KO猪后表现出强烈的免疫反应,其特征为大量炎性细胞浸润、异物巨细胞的存在、抗αGal抗体滴度急剧增加以及最终移植物的破坏,而野生型猪移植物在GGTA1-KO猪中仅诱导轻微反应。同种异体植入物,即野生型/野生型和GGTA1-KO/GGTA1-KO瓣膜未诱导可测量的免疫反应。因此,GGTA1-KO猪对去细胞化异种植入物产生了“类人”免疫反应,表明去细胞化不足以降低异种植入物的免疫原性,这削弱了它们的再生潜力。